Patient acceptance and outcome of mental health screening in Swedish adults with cystic fibrosis.
Adolescent
Adult
Aged
Anxiety
/ diagnosis
Anxiety Disorders
/ psychology
Cystic Fibrosis
/ psychology
Depression
/ diagnosis
Depressive Disorder
/ psychology
Female
Humans
Male
Mass Screening
/ methods
Mental Health
/ statistics & numerical data
Middle Aged
Quality of Life
/ psychology
Sweden
Young Adult
Anxiety
Cystic fibrosis
Depression
Patient acceptance of health care
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
accepted:
02
01
2020
pubmed:
11
1
2020
medline:
24
7
2020
entrez:
11
1
2020
Statut:
ppublish
Résumé
Anxiety and depression are common among adults with cystic fibrosis (CF), and the International Committee on Mental Health in CF (ICMH) recommends annual screening for mental health problems. We implemented screening according to the recently published guidelines and assessed the results from the first year, as well as the patients' attitude to annual screening METHODS: Adult patients attending Gothenburg CF-center from Feb 2015 to Dec 2016 completed the GAD-7 (anxiety) and PHQ-9 (depression) forms at the time of their annual review. In addition, questions regarding the screening process and instruments used were asked. All invited patients (n = 100, 52% males, 2% lung transplanted), with a median age of 28 years (range 18-65), agreed to participate. In general (83%), the patients were positive to screening on an annual basis. No significant differences in total GAD-7 and PHQ-9 scores were found when comparing men and women. Patients younger than 30 years of age reported more symptoms of anxiety compared to older patients (p = 0.02). There were 21 (21%) patients with scores > 10 for GAD-7 and/or PHQ-9 indicating at least moderate anxiety or depression. Scores > 10 were reported by 15 patients on GAD-7, 15 patients on PHQ-9, and 9 patients reported scores above 10 on both measures. The patients considered annual check-ups for mental health issues important. Although the screening results are reassuring, the group is heterogenic and younger individuals should be given extra attention. Follow-up over longer time will provide more robust data.
Identifiants
pubmed: 31919786
doi: 10.1007/s11136-020-02417-5
pii: 10.1007/s11136-020-02417-5
pmc: PMC7253508
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1579-1585Références
Elborn, J. S. (2016). Cystic fibrosis. The Lancet,388(10059), 2519–2531.
doi: 10.1016/S0140-6736(16)00576-6
Burgel, P.-R., Bellis, G., Olesen, H. V., Viviani, L., Zolin, A., Blasi, F., et al. (2015). Future trends in cystic fibrosis demography in 34 European countries. European Respiratory Journal,46(1), 133–141.
doi: 10.1183/09031936.00196314
Clancy, J. P., Cotton, C. U., Donaldson, S. H., Solomon, G. M., VanDevanter, D. R., Boyle, M. P., et al. (2019). CFTR modulator theratyping: Current status, gaps and future directions. Journal of Cystic Fibrosis,18(1), 22–34.
doi: 10.1016/j.jcf.2018.05.004
Elborn, J. S., Bell, S. C., Madge, S. L., Burgel, P.-R., Castellani, C., Conway, S., et al. (2016). Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis. European Respiratory Journal,47(2), 420–428.
doi: 10.1183/13993003.00592-2015
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., et al. (2019). The future of cystic fibrosis care: A global perspective. The Lancet Respiratory Medicine,8(1), 65–124.
doi: 10.1016/S2213-2600(19)30337-6
Quittner, A. L., Goldbeck, L., Abbott, J., Duff, A., Lambrecht, P., Solé, A., et al. (2014). Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: Results of The International Depression Epidemiological Study across nine countries. Thorax,69(12), 1090–1097.
doi: 10.1136/thoraxjnl-2014-205983
Quittner, A. L., Barker, D. H., Snell, C., Grimley, M. E., Marciel, K., & Cruz, I. (2008). Prevalence and impact of depression in cystic fibrosis. Current Opinion in Pulmonary Medicine,14(6), 582–588.
doi: 10.1097/MCP.0b013e3283121cf1
Cruz I, Marciel KK, Quittner AL, Schechter MS. Anxiety and depression in cystic fibrosis. Seminars in Respiratory and Critical Care Medicine; 2009; 30(5): 569–578.
doi: 10.1055/s-0029-1238915
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet,367(9524), 1747–1757.
doi: 10.1016/S0140-6736(06)68770-9
Johansson, R., Carlbring, P., Heedman, Å., Paxling, B., & Andersson, G. (2013). Depression, anxiety and their comorbidity in the Swedish general population: Point prevalence and the effect on health-related quality of life. PeerJ,1, e98.
doi: 10.7717/peerj.98
Backström-Eriksson, L., Sorjonen, K., Brucefors, A., Hjelte, L., & Melin, B. (2015). Anxiety and depression in adults with cystic fibrosis: A comparison between patients and the general population in Sweden and three other European countries. BMC Pulmonary Medicine,15(1), 121.
doi: 10.1186/s12890-015-0117-9
Brucefors, A. B., Hjelte, L., & Hochwälder, J. (2011). Mental health and sense of coherence among Swedish adults with cystic fibrosis. Scandinavian Journal of Caring Sciences,25(2), 365–372.
doi: 10.1111/j.1471-6712.2010.00840.x
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., et al. (2016). International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax,71(1), 26–34.
doi: 10.1136/thoraxjnl-2015-207488
Abbott, J., Havermans, T., Jarvholm, S., Landau, E., Prins, Y., Smrekar, U., et al. (2019). Mental Health screening in cystic fibrosis centres across Europe. Journal of Cystic Fibrosis,18(2), 299–303.
doi: 10.1016/j.jcf.2018.09.003
Verkleij, M., de Winter, D., Hurley, M. A., & Abbott, J. (2018). Implementing the International Committee on Mental Health in Cystic Fibrosis (ICMH) guidelines: Screening accuracy and referral-treatment pathways. Journal of Cystic Fibrosis,17(6), 821–827.
doi: 10.1016/j.jcf.2018.02.005
Järvholm, S., Hufnagl, M., Höglund, S., Ericson, P., & Gilljam, M. (2017). Outcome and patient acceptance of mental screening among adults with CF. Journal of Cystic Fibrosis,16, S11–S12.
doi: 10.1016/S1569-1993(17)30193-5
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine,16(9), 606–613.
doi: 10.1046/j.1525-1497.2001.016009606.x
Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. General Hospital Psychiatry,32(4), 345–359.
doi: 10.1016/j.genhosppsych.2010.03.006
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders,114(1–3), 163–173.
doi: 10.1016/j.jad.2008.06.026
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine,166(10), 1092–1097.
doi: 10.1001/archinte.166.10.1092
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., et al. (2008). Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical Care,46(3), 266–274.
doi: 10.1097/MLR.0b013e318160d093
Association, W. M. (1997). Recommendations guiding physicians in biomedical research involving human subjects World Medical Association Declaration of Helsinki. JAMA,277(11), 925–926.
doi: 10.1001/jama.1997.03540350075038
Catastini, P., Di Marco, S., Furriolo, M., Genovese, C., Grande, A., Iacinti, E., et al. (2016). The prevalence of anxiety and depression in Italian patients with cystic fibrosis and their caregivers. Pediatric Pulmonology,51(12), 1311–1319.
doi: 10.1002/ppul.23566
Wikman S. (2018) Unga mår allt sämre-eller?: Kunskapsöversikt om ungas psykiska hälsa i Sverige 2018. Mind.
Arnett, J. J. (2000). Emerging adulthood: A theory of development from the late teens through the twenties. American Psychologist,55(5), 469.
doi: 10.1037/0003-066X.55.5.469
Folkhälsomyndigheten. (2014) Nationella folkhälsoenkäten-Hälsa på lika villkor. Folkhälsomyndigheten Solna.
Tuchman, L. K., Schwartz, L. A., Sawicki, G. S., & Britto, M. T. (2010). Cystic fibrosis and transition to adult medical care. Pediatrics,125(3), 566–573.
doi: 10.1542/peds.2009-2791
Askew, K., Bamford, J., Hudson, N., Moratelli, J., Miller, R., Anderson, A., et al. (2017). Current characteristics, challenges and coping strategies of young people with cystic fibrosis as they transition to adulthood. Clinical Medicine,17(2), 121–125.
doi: 10.7861/clinmedicine.17-2-121
Besier, T., & Goldbeck, L. (2012). Growing up with cystic fibrosis: Achievement, life satisfaction, and mental health. Quality of Life Research,21(10), 1829–1835.
doi: 10.1007/s11136-011-0096-0
Steptoe, A., & Marmot, M. (2003). Burden of psychosocial adversity and vulnerability in middle age: Associations with biobehavioral risk factors and quality of life. Psychosomatic Medicine,65(6), 1029–1037.
doi: 10.1097/01.PSY.0000097347.57237.2D
Verhaak, P. F., Heijmans, M. J., Peters, L., & Rijken, M. (2005). Chronic disease and mental disorder. Social Science and Medicine,60(4), 789–797.
doi: 10.1016/j.socscimed.2004.06.012